The Division of Nuclear Medicine Imaging and Therapy at Penn Radiology, also known as Penn Nuclear Medicine, is the site of the first human FDG PET image and the birthplace of nuclear tomographic imaging. Innovation and invention support our comprehensive approach to the Penn Medicine tripartite mission of clinical care, education and research, in the full spectrum of nuclear medicine.
Our overarching goal is to help move the broad field of nuclear medicine/molecular imaging forward through excellent state-of-the-art clinical care, diligent teaching of the future specialists in the field as well as innovative and impactful research.
The Division is made up of ABNM-certified physicians, biologists, chemists, pharmacists and physicists as well as nuclear medicine technologists, nurses and administrative staff. Medical students, graduate students, post-doctoral researchers, residents and fellows are instrumental in our continued progress.
Clinical Care
The Division of Nuclear Medicine Imaging and Therapy performs a full spectrum of current state-of-the-art care including PET CT, Single photon nuclear imaging, cardiac imaging and radiopharmaceutical therapy. Building on our busy clinical practice across several sites in the Philadelphia area, we seek to positively impact as wide a spectrum of patients as possible. Our expertise is broad across clinical areas with clinicians specializing in such fields as neuroimaging, cancer, cardiac imaging and physiology and musculoskeletal disorders.
Explore our clinical service offerings and meet our clinical team
Education and Training
Penn Nuclear Medicine participates in the departments diagnostic radiology residency, and the division maintains an ACGME-certified nuclear radiology fellowship program that can be embedded via the 16-month pathway into the diagnostic radiology residency, or as a standalone one-year post residency fellowship. The [FC1] program meets all curricular requirements for both nuclear radiology and nuclear medicine board eligibility. Medical student rotations and research experiences, graduate and medical school courses, observerships and CME programs round out the divisions educational offerings.
Research
It is our aim to expand the currently available nuclear medicine techniques through research. From researchers working on basic chemistry and physics for new probe and instrument development, respectively, to pre-clinical testing and validation, through clinical trials and post-marketing clinical research, our team collectively encompasses the breadth of the field. Complete with a cyclotron facility at the PET Center containing two cyclotrons and a GMP manufacturing facility, the Division is able to carry out clinical research and pre-clinical radiopharmaceutical production.